Key result
Echocardiographic global pulse wave velocity lacks validated prognostic value for clinical HFpEF.
Why the study?
The independent contribution of arterial stiffness to hypertensive LVDD and the incremental value of pulse wave velocity beyond established echocardiographic markers in contemporary HFpEF assessment require clarification.
While arterial stiffness is a biologically plausible contributor to hypertensive ventricular remodeling and impaired diastolic reserve, echocardiographic global pulse wave velocity currently serves only as a complementary, hypothesis-generating measure rather than a validated diagnostic or prognostic marker for clinical HFpEF.
Answers are grounded in this paper and cite their sources.
PWV lacks support as independent HFpEF diagnostic or prognostic marker; leaves open adjunctive phenotyping role pending prospective validation.
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of heart failure cases and is closely associated with hypertension and left ventricular diastolic dysfunction (LVDD). This narrative review examines the relationship between diastolic function, arterial stiffness, and ventricular-arterial coupling in hypertensive heart disease. We summarize ventricular relaxation and filling and discuss echocardiographic measures, including E/e', left atrial volume, and left atrial reservoir strain, for assessing diastolic function and filling pressures. We then examine how aortic stiffening may increase late systolic load and contribute to ventricular remodeling and impaired relaxation. This review addresses four central questions: whether arterial stiffness represents an independent component of hypertensive left ventricular diastolic dysfunction; whether pulse wave velocity (PWV) is primarily a marker of vascular aging, ventricular afterload, or HFpEF risk; whether PWV provides incremental information beyond established echocardiographic markers; and how arterial stiffness could be integrated into contemporary HFpEF assessment. The available evidence supports arterial stiffness as a biologically plausible contributor to hypertensive ventricular remodeling and impaired diastolic reserve. However, current evidence does not establish echocardiographic global PWV (PWVg) as an independent diagnostic criterion or validated prognostic marker of clinical HFpEF. We therefore propose PWVg as a complementary, hypothesis-generating measure for vascular and ventricular phenotyping, to be interpreted alongside clinical assessment, natriuretic peptides, multiparametric echocardiography, and exercise or invasive hemodynamic testing when indicated.
No takes yet. Share an insight, caveat, or question.
Palmiero et al. (2026) conducted a review in Hypertension, left ventricular diastolic dysfunction (LVDD), and heart failure with preserved ejection fraction (HFpEF). Echocardiographic global pulse wave velocity (PWVg) and arterial stiffness assessment vs. Established echocardiographic markers (E/e', left atrial volume, left atrial reservoir strain), natriuretic peptides, and hemodynamic testing was evaluated. Arterial stiffness contributes to hypertensive ventricular remodeling, though echocardiographic global pulse wave velocity is not yet a validated prognostic marker for clinical HFpEF.
Synapse has enriched 10 related papers. Consider them for comparative context: